
Pfizer announced that the FDA has approved its supplemental New Drug Application for EUCRISA ointment in treating 3 month year …
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns

